minoxidil has been researched along with Disease Models, Animal in 20 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As an extension to these observations, we chose to test the efficacy of minoxidil, a drug known to be a hypertrichotic agent, in preventing chemotherapy-induced alopecia in the newborn rat animal model." | 7.69 | Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model. ( Hussein, AM, 1995) |
| "Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata." | 6.16 | Minoxidil. ( Fiedler-Weiss, VC, 1987) |
| " Minoxidil (MXD) is commonly used topically to treat alopecia, but its low absorption rate limits widespread use." | 5.72 | Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model. ( An, BS; Jeong, JS; Kim, DS; Kim, MJ; Kim, SY; Lee, S; Seong, KY; Yang, SY, 2022) |
| "Minoxidil (Mx) is a conventional drug for treating androgenetic alopecia, preventing hair loss, and promoting hair growth." | 3.83 | Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth. ( Chen, HK; Liao, AH; Lin, YC; Lu, YJ; Sytwu, HK; Wang, CH, 2016) |
| "As an extension to these observations, we chose to test the efficacy of minoxidil, a drug known to be a hypertrichotic agent, in preventing chemotherapy-induced alopecia in the newborn rat animal model." | 3.69 | Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model. ( Hussein, AM, 1995) |
| "The authors studied the effects of vasodilator treatment with either hydralazine or minoxidil on gas exchange and lung water accumulation over a 5-h period in canine oleic acid-induced pulmonary edema." | 3.67 | Vasodilators worsen gas exchange in dog oleic-acid lung injury. ( Bishop, MJ; Cheney, FW, 1986) |
| " Minoxidil (MXD) is commonly used topically to treat alopecia, but its low absorption rate limits widespread use." | 1.72 | Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model. ( An, BS; Jeong, JS; Kim, DS; Kim, MJ; Kim, SY; Lee, S; Seong, KY; Yang, SY, 2022) |
| "The data demonstrate that hair loss in the AGA mouse is androgen dependent and that this mutant strain can serve as a suitable model for the screening of compounds, such as antiandrogens and vasodilators, which may influence the balding process." | 1.28 | Animal models of androgen-dependent disorders of the pilosebaceous apparatus. 1. The androchronogenetic alopecia (AGA) mouse as a model for male-pattern baldness. ( Malloy, V; Matias, JR; Orentreich, N, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Wu, ZJ | 1 |
| Ibrahim, MM | 1 |
| Sergesketter, AR | 1 |
| Schweller, RM | 1 |
| Phillips, BT | 1 |
| Klitzman, B | 1 |
| Kim, MJ | 1 |
| Seong, KY | 1 |
| Kim, DS | 1 |
| Jeong, JS | 1 |
| Kim, SY | 1 |
| Lee, S | 1 |
| Yang, SY | 1 |
| An, BS | 1 |
| Anderson, ZT | 1 |
| Palmer, JW | 1 |
| Idris, MI | 1 |
| Villavicencio, KM | 1 |
| Le, G | 1 |
| Cowart, J | 1 |
| Weinstein, DE | 1 |
| Harris, ML | 1 |
| Chen, YF | 2 |
| Chen, LH | 1 |
| Yeh, YM | 1 |
| Wu, PY | 1 |
| Chang, LY | 1 |
| Chang, JY | 1 |
| Shen, MR | 1 |
| Liao, AH | 1 |
| Lu, YJ | 1 |
| Lin, YC | 1 |
| Chen, HK | 1 |
| Sytwu, HK | 1 |
| Wang, CH | 1 |
| Thunhorst, RL | 1 |
| Beltz, TG | 1 |
| Johnson, AK | 1 |
| Polizio, AH | 1 |
| Gorzalczany, SB | 1 |
| Tomaro, ML | 1 |
| Gu, YT | 1 |
| Xue, YX | 1 |
| Zhang, H | 1 |
| Li, Y | 1 |
| Liang, XY | 1 |
| Chen, CH | 1 |
| Sheu, MT | 1 |
| Wu, AB | 1 |
| Lin, KP | 1 |
| Ho, HO | 1 |
| Pals, DT | 1 |
| Orley, J | 1 |
| Hussein, AM | 1 |
| Kimura, T | 1 |
| Leenen, FH | 1 |
| Yuan, B | 1 |
| Shirai, A | 1 |
| Ikeda, J | 1 |
| Kawashima, S | 1 |
| Tamaoki, T | 1 |
| Kamiya, T | 1 |
| Pick, R | 1 |
| Glick, G | 1 |
| Matias, JR | 1 |
| Malloy, V | 1 |
| Orentreich, N | 1 |
| Fiedler-Weiss, VC | 1 |
| Bishop, MJ | 1 |
| Cheney, FW | 1 |
2 reviews available for minoxidil and Disease Models, Animal
| Article | Year |
|---|---|
Studies on development of hairless descendants of Mexican hairless dogs and their usefulness in dermatological science.
Topics: Animals; Blood Cell Count; Breeding; Dermatitis, Allergic Contact; Dermatology; Dihydroxyphenylalani | 1996 |
Minoxidil.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Animals; Cells, Cultured; Child; Clinical Trials as Topic; | 1987 |
1 trial available for minoxidil and Disease Models, Animal
| Article | Year |
|---|---|
Minoxidil.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Animals; Cells, Cultured; Child; Clinical Trials as Topic; | 1987 |
18 other studies available for minoxidil and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
The Influence of Topical Vasodilator-Induced Pharmacologic Delay on Cutaneous Flap Viability and Vascular Remodeling.
Topics: Administration, Cutaneous; Animals; Disease Models, Animal; Graft Survival; Iloprost; Male; Minoxidi | 2022 |
Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model.
Topics: Alopecia; Animals; Antineoplastic Agents; Disease Models, Animal; Hyaluronic Acid; Mice; Minoxidil | 2022 |
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation-induced canities.
Topics: Administration, Topical; Animals; Cyclosporine; Dermatologic Agents; Disease Models, Animal; Drug Co | 2021 |
Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
Topics: Alopecia; Animals; Antineoplastic Agents, Phytogenic; Calcium; Cell Line, Tumor; Disease Models, Ani | 2017 |
Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth.
Topics: Albumins; Alopecia; Animals; Chitosan; Disease Models, Animal; Drug Delivery Systems; Hair; Mice, In | 2016 |
Hypotension- and osmotically induced thirst in old Brown Norway rats.
Topics: Age Factors; Aging; Animals; Blood Pressure; Dehydration; Disease Models, Animal; Diuresis; Drinking | 2009 |
Lowering arterial pressure delays the oxidative stress generation in a renal experimental model of hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Heme Oxyg | 2009 |
Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Capillaries; Caveolin 1; Disease Models, Animal; Evan | 2011 |
Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
Topics: Administration, Topical; Alopecia; Animals; Disease Models, Animal; Drug Carriers; Hair; Male; Mice; | 2005 |
A nonhuman primate model for evaluating the potential of antihypertensive drugs to cause orthostatic hypotension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chlorisondamine; Disease Models, Animal; Hypotensi | 1983 |
Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model.
Topics: Alopecia; Animals; Animals, Newborn; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Disease Mo | 1995 |
Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Pressure; Cardiomegaly; Coronary Disease; Coronary Ves | 2001 |
KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models.
Topics: Alopecia; Animals; Cells, Cultured; Culture Techniques; Dermatologic Agents; Disease Models, Animal; | 2001 |
Effects of propranolol, minoxidil, and clofibrate on cholesterol-induced atherosclerosis in stumptail macaques (Macaca arctoides).
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Clofibrate; Coronary Disease; Coronary Vessels; Diet, | 1977 |
Animal models of androgen-dependent disorders of the pilosebaceous apparatus. 1. The androchronogenetic alopecia (AGA) mouse as a model for male-pattern baldness.
Topics: Alopecia; Androgens; Animals; Antihypertensive Agents; Disease Models, Animal; Female; Male; Mice; M | 1989 |
Vasodilators worsen gas exchange in dog oleic-acid lung injury.
Topics: Animals; Cardiac Output; Disease Models, Animal; Dogs; Hemodynamics; Hydralazine; Minoxidil; Oleic A | 1986 |